| __timestamp | Bausch Health Companies Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 35942000 |
| Thursday, January 1, 2015 | 2682700000 | 40028000 |
| Friday, January 1, 2016 | 2810000000 | 45853000 |
| Sunday, January 1, 2017 | 2582000000 | 53816000 |
| Monday, January 1, 2018 | 2473000000 | 60804000 |
| Tuesday, January 1, 2019 | 2554000000 | 77252000 |
| Wednesday, January 1, 2020 | 2367000000 | 45736000 |
| Friday, January 1, 2021 | 2624000000 | 50323000 |
| Saturday, January 1, 2022 | 2625000000 | 143526000 |
| Sunday, January 1, 2023 | 2917000000 | 149182000 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical industry, understanding the financial dynamics of key players is crucial. Over the past decade, from 2014 to 2023, Bausch Health Companies Inc. and Halozyme Therapeutics, Inc. have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses.
Bausch Health, a giant in the sector, consistently reported SG&A expenses averaging around $2.57 billion annually. Despite fluctuations, their expenses peaked in 2023, marking a 44% increase from 2014. In contrast, Halozyme, a smaller yet innovative player, saw its SG&A expenses grow significantly, with a remarkable 315% increase over the same period. This surge reflects Halozyme's strategic investments in growth and expansion.
These trends highlight the diverse strategies employed by pharmaceutical companies in managing operational costs, offering valuable insights into their financial health and market positioning.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Bausch Health Companies Inc.
Comparing SG&A Expenses: Johnson & Johnson vs Bausch Health Companies Inc. Trends and Insights
Halozyme Therapeutics, Inc. and Apellis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Halozyme Therapeutics, Inc. or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Blueprint Medicines Corporation and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Bausch Health Companies Inc. vs ImmunityBio, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared